скрининг

Urinalysis is the most commonly used method of assessing and monitoring of the patient in urological practice. 

Objective: to estimate the diagnostic value of the portable urine analyzer "ETTA AMP-01" for subsequent use as a tool for patient-centered urology (mHealth) with proven efficacy. 

Prostate cancer (PCa) – one of the most common diseases among the male population of the world, providing a major impact on world health and economy. It is believed that the disease within the first 15 years after detection is relatively indolent, and a significant increase in mortality rates is observed after 15 years. High popularity of screening led to overdiagnosis, ie, the detection of clinically insignificant prostate cancer.

At present time the challenge of prostate cancer early detection becomes more and more vital due to prostate cancer (PCa) is one of the most common malignant tumors in males. Development and clinical introduction of programs of prostate cancer early detection is not only about a medical concern but about social and economic meaning for government. After introduction 20 years ago PSA test gave a start to early prostate cancer detection era, increased rate of localized curable cancer detection.